The Role of Radiotherapy in oseosarcoma

Cancer Treatment and Research

Volumn 152, Issue , 2009, Pages 147-164

  Schwarz, Rudolf ^a   Bruland, Oyvind ^a   Cassoni, Anna ^a   Schomberg, Paula ^a   Bielack, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; LEXIDRONAM SAMARIUM SM 153; METHOTREXATE;

ADOLESCENT; ADULT; AGED; BONE BIOPSY; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DRUG MEGADOSE; FOLLOW UP; HUMAN; INTRAOPERATIVE RADIOTHERAPY; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; NEUTRON THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTON THERAPY; RADIATION DOSE; SCHOOL CHILD; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT PLANNING; TREATMENT RESPONSE; BONE NEOPLASMS; MIDDLE AGED; MORTALITY;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; MIDDLE AGED; OSTEOSARCOMA;

EID: 77953662028     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0284-9_7     Document Type: Conference Paper

References (60)

1. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico/osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000;18:4016-4027.
2. Bielack S, Kempf-Bielack B, Schwenzer D, et al. Neoadjuvante Therapie des lokalisierten Osteosarkoms der Extremitäten. Erfahrungen der Cooperativen Osteosarkomstudiengruppe COSS an 925 Patienten. Klin Paediatr. 1999;211:260-270.
3. Ferguson WS, Goorin AM. Current treatment of osteosarcoma. Cancer Invest. 2001;19:292-315.
4. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1997;15:76-84.
5. Weis LD. The success of limb-salvage surgery in the adolescent patient with osteogenic sarcoma. Adolesc Med. 1999;10:451-458.
6. Lindner NJ, Ramm O, Hillmann A, et al. Limb salvage and outcome of osteosarcoma: the University of Muenster experience. Clin Orthop. 1999;358:83-89.
7. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1, 702 patients treated on neoadjuvant cooperative oseosarcoma study group protocols. J Clin Oncol. 2002;20:776-790.
8. Picci P, Sangiorgi L, Bahamonde L, et al. Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcomas of the extremities. Ann Oncol. 1997;8:899-903.
9. Ozaki T, Flege S, Kevric M, et al. Osteosarcoma of the pelvis: experience of the cooperative osteosarcoma study group. J Clin Oncol. 2003;21:334-341.
10. Ozaki T, Flege S, Liljenqvist U, et al. Osteosarcoma of the spine: experience of the cooperative osteosarcoma study group. Cancer. 2002;94:1069-1077.
11. Kassir RR, Rassekh CH, Kinsella JB, et al. Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope. 1997;107:56-61.
12. Jenkin RD, Allt W, Fitzpatrick PJ. Osteosarcoma: an assessment of management with particular reference to primary irradiation and selective delayed amputation. Cancer. 1972;2:393-400.
13. De Moor NG. Osteosarcoma: a review of 72 cases treated by megavoltage radiation therapy, with or without surgery. S Afr J Surg. 1975;13:137-146.
14. Beck JC, Wara WM, Bovill EG Jr, et al. The role of radiation therapy in the treatment of osteosarcoma. Radiology. 1976;120:163-165.
15. Cade S. Osteogenic sarcoma: a study based on 133 patients. J R Coll Surg Edinb. 1955;1:79-111.
16. Gaitan-Yanguas M. A study of the response of osteogenic sarcoma and adjacent normal tissues to radiation. Int J Radiat Oncol Biol Phys. 1981;7:593-595.
17. Machak GN, Tkachev SI, Solovyev YN, et al. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clin Proc. 2003;78:147-155.
18. DeLaney TF, Park L, Goldberg SI, et al. Radiotherapy for local control of osteosarcoma. Int J Rad Oncol Biol Phys. 2005;61:492-498.
19. Bruland øS, Skretting A, Solheim øP, et al. Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach. Acta Oncologica. 1996;35:381-384.
20. Bruland øS, Skretting A, Saeter G, et al. Targeted internal radiotherapy in osteosarcoma patients using 153Sm-EDTMP. Med Ped Oncol. 1996;27:215.
21. Bruland øS, Phil A. On the current management of osteosarcoma: a critical evaluation and proposal for a modified treatment strategy. Eur J Cancer. 1997;33:1725-1731.
22. Anderson PM, Wisemann GA, Dispenzieri A, et al. High-dose samarium-153 ethylene diamnine tetramethylene phosphonate phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol. 2002;20:189-196.
23. Franzius C, Bielack S, Sciuk J, et al. High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma. Nuklearmedizin. 1999;38:337-340.
24. Franzius C, Schuck A, Bielack SS. High-dose Samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol. 2002;20:1953-1954.
25. Kempf-Bielack B, Bielack SS, Jürgens H, et al. Osteosarcoma Relapse after combined modality therapy: an analysis of unselected patients in the cooperative osteosarcoma study group (COSS). J Clin Oncol. 2005;23:559-568.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
27. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1996;50:163-170.
28. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc (B). 1972;34:187-220.
29. Larsen RH, Bruland øS, Hoff Å, et al. Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody; comparison with Astatine-21-labelled bovine serum albumon, free Astatine-211 and external-beam X rays. Rad Res. 1994;139:178-184.
30. Larsen RH, Bruland øS, Hoff P, et al. Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibodies. Br J Cancer. 1994;69:1000-1005.
31. Olsen DR, Bruland øS. Is osteosarcoma a radioresistant tumor? Towards the Eradication of Osteosarcoma Metastases - An Odyssey. The Norwegian Radium Hospital; 1998:73-76.
32. Sundaresan N, Rosen G, Ag H, et al. Combined treatment of osteosarcoma of the spine. Neurosurgery. 1988;23:714-719.
33. Caceres E, Zaharia M, Valdivia S, et al. Local control of osteogenic sarcoma by radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1984;10:35-39.
34. Lombardi F, Gandola L, Fossati-Belani F, et al. Hypofractionated accelerated radiotherapy in osteogenic sarcoma. Int J Rad Oncol Biol Phys. 1992;24:761-765.
35. Calvo FA, Ortiz de Urbina D, Sierrasesumaga L, et al. Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents. Med Pediatr Oncol. 1991;19:478-485.
36. Hong A, Stevens G, Stalley P, et al. Extracorporeal irradiation for malignant bone tumors. Int J Radiat Oncol Biol Phys. 2001;50:441-447.
37. Oya N, Kokubo M, Mizowaki T, et al. Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities. Int J Radiat Oncol Biol Phys. 2001;51:87-93.
38. Sabo D, Bernd L, Buchner M, et al. Intraoperative extracorporeal irradiation and replantation in local treatment of primary malignant bone tumors. Orthopäde. 2003;32:1103-1112.
39. Uhl V, Castro JR, Knopf K, et al. Preliminary results in heavy charged particle irradiation of bone sarcoma. Int J Radiat Oncol Biol Phys. 1992;24:755-759.
40. Castro JR, Linstadt DE, Bhary JP, et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys. 1994;29:647-655.
41. Hug EB, Munzenrieder JE. Charged particle therapy for base of skull tumors: Past accomplishments and future challenges. Int J Radiat Oncol Biol Phys. 1994;29:911-919.
42. Kamada T, Tsujii H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol. 2002;20:4466-4471.
43. Chambers RG, Mahoney WD. Osteogenic sarcoma of the mandible, current management. Am Surg. 1970;36:463-471.
44. Eilber FR, Morton DL, Eckhardt J, et al. Limb salvage for skeletal and soft tissue sarcomas: multidisciplinary preoperative therapy. Cancer. 1984;53:2579-2584.
45. Dincbas FO, Koca S, Mandel NM, et al. The role of preoperative radiotherapy in nonmetastatic high-grade osteosarcoma of the extremities for limb-sparing surgery. Int J Radiat Oncol Biol Phys. 2005;62:820-828.
46. Carrie C, Breteau N, Negrier S, et al. The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary report. Med Pediatr Onco. 1994;22:355-357.
47. Burgers JM, Van Glabbeke M, Busson A, et al. Osteosarcoma of the limbs. Report of the EORTC-SIOP03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation. Cancer. 1988;61:1024-1031.
48. Whelan JS, Burcombe RJ, Janinis J, et al. A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann Oncol. 2002;13:23-30.
49. Appelbaum FR, Sandmaier B, Brown PA, et al. Myelosuppression and mechanism of recovery following administration of 153Samarium-EDTMP. Antibody Imunoconjug Radiopharm. 1988;1:263-270.
50. Turner JH, Claringbold PG, Heytherington EL. A phase I study of samarium 153 ethylene diamine tetramethylene phosphonate therapy for dissiminated skeletal metastases. J Clin Oncol. 1989;7:1926-1931.
51. Turner JH, Martindale AA, Sorby P. Samarium 153EDTMP therapy of dissiminated skeletal metastasis. Eur J Nucl Med. 1989;15:784-795.
52. Franzius C, Bielack S, Sciuk J, et al. High-activity samarium-EDTMP therapy followed by autologues peripheral blood stem cell support in unresectable osteosarcoma. Nuklearmedizin. 2001;40:215-220.
53. Mahajan A, Woo SY, Kornguth DG, et al. Multimodality treatment of Osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer. 2007;. doi:10.1002/pbc.21451.
54. Anderson PM. Effectiveness of radiotherapy for osteosarcoma that responds to chemotherapy. Mayo Clin Proc. 2003;78:145-146.
55. Jaffe N, Knapp J, Chuang VP, et al. Osteosarcomas: Intra-arterial treatment of the primary tumor with Cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies. Cancer. 1983;51:402-407.
56. Kinsella TJ, Glatstein E. Clinical experience with intravenous radiosensitizers in unresectable sarcomas. Cancer. 1987;59:908-915.
57. Estrada-Aguilar J, Greenberg H, Walling A, et al. Primary treatment of pelvic osteosarcoma. Cancer. 1992;69:1137-1145.
58. Martinez A, Goffinet DR, Donaldson SS, et al. Intra-arterial infusion of radiosensitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma. Int J Radiat Oncol Biol Phys. 1985;11:123-128.
59. Anderson PM (2002) Samarium + gemcitabine concept. Presented at: Children's Oncology Group meeting; October 26, St. Louis, Mo.
60. Anderson P, Aguilera D, Pearson M, et al. Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents. Cancer Control. 2008;15:38-46.